REGENXBIO Inc. RGNX
REGENXBIO Inc. statistics & valuation
Market cap$541.8M
P / S3.2×
P / B5.3×
Net margin-113.8%
Return on equity-188.7%
FCF margin-74.1%
Return on capital-48.1%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -94.6% | -280.0% | -297.1% | -233.2% | 34.0% | -77.1% | -422.9% | 40.3% | -730.2% | -1423.8% |
| Net margin | -113.8% | -272.5% | -292.0% | -248.7% | 27.2% | -72.0% | -268.9% | 45.7% | -704.0% | -1372.1% |
| FCF margin | -74.1% | -210.7% | -253.1% | -211.3% | 28.6% | -52.4% | -339.0% | 41.8% | -626.9% | -1235.7% |
| Return on assets | -42.8% | -48.7% | -45.9% | -33.6% | 11.5% | -15.7% | -19.0% | 18.4% | -36.8% | -36.5% |
| Return on equity | -188.7% | -87.5% | -84.5% | -54.3% | 16.7% | -29.5% | -21.0% | 19.6% | -40.0% | -38.9% |
| Current ratio | 2.38 | 2.69 | 2.57 | 3.19 | 3.98 | 6.52 | 10.25 | 15.24 | 11.64 | 9.66 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.